AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11100345
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of absolute ethanol + octreotide (n = 42)
Trial: 11100345
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of absolute ethanol + omeprazole (n = 40)
Trial: 11941338
Drug: Nonextraction orthodontic
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonextraction orthodontic treatment
Trial: 11941338
Drug: Extraction orthodontic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraction orthodontic treatment
Trial: 8462205
Drug: Dermatan sulfate
RxNorm normalized name: dermatan sulfate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulfate (DS) 6 mg/kg body weight
Trial: 8462205
Drug: Standard heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard heparin treatment
Trial: 3756057
Drug: Metoprolol (M)
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol (M) 0.2 mg kg‐1 i.v. and dihydralazine (DH) 0.2 mg kg‐1 i.v.
Trial: 3756057
Drug: Dihydralazine (DH)
RxNorm normalized name: dihydralazine
DrugBank: Dihydralazine (DB12945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydralazine (DH) 0.2 mg kg‐1 i.v. alone
Trial: 29776872
Drug: Oral Glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Glucose
Trial: 25987694
Drug: Enoxaparin (low-molecular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (low-molecular weight heparin)
Trial: 25987694
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (observation group)
Trial: 17512256
Drug: Intravenous amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amitriptyline 25 mg
Trial: 17512256
Drug: Intravenous amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amitriptyline 50 mg
Trial: 17512256
Drug: Intravenous amitriptyline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amitriptyline 100 mg
Trial: 15152535
Drug: Rectal naproxen
RxNorm normalized name: naproxen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal naproxen
Trial: 2453226
Drug: Peroral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peroral administration
Trial: 2453226
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration
Trial: 23985411
Drug: Sildenafil (started
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (started 2 weeks before surgery and continued postoperatively at 0.5 mg/kg, increased to a maximum of 2 mg/kg)
Trial: 23985411
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (sildenafil started only postoperatively at 0.5 mg/kg, increased to a maximum of 2 mg/kg)
Trial: 16503536
Drug: Trimetazidine 20
RxNorm normalized name: trimetazidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine 20 mg 3 times daily for 8 weeks
Trial: 16503536
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy (Control group A)
Trial: 14550702
Drug: Vibrating gel-based
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vibrating gel-based insoles
Trial: 8936659
Drug: Corticosteroid (prednisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid (prednisone 1 mg/kg/day in decreasing doses)
Trial: 6388810
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy for first breast cancer
Trial: 23628617
Drug: Lixisenatide 20
RxNorm normalized name: lixisenatide 20 mcg/0.2 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide 20 μg
Trial: 29548848
Drug: Resveratrol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol (200 mg/day) for 26 weeks
Trial: 27144849
Drug: Rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (20 mg daily)
Trial: 20629075
Drug: Rotigotine 2
RxNorm normalized name: ROTIGOTINE 2MG/24HRS PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine 2 mg/24 hr
Trial: 20629075
Drug: Rotigotine 3
RxNorm normalized name: ROTIGOTINE 3MG/24HRS PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine 3 mg/24 hr
Trial: 15546135
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose melphalan (180 mg/m²) with autologous bone marrow support
Trial: 10420071
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) 1 mg/kg body weight
Trial: 10420071
Drug: Combined LMWH-adjusted
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined LMWH-adjusted dose plus UFH 2,500 IU fix dose (ComHep)
Trial: 10420071
Drug: UFH 2,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH 2,500 IU fix dose (FixUFH)
Trial: 22442350
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who continued maintenance or received a second high-dose melphalan
Trial: 12800397
Drug: Thrombolytic infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thrombolytic infusion during transport to PCI center for coronary angioplasty (Group B)
Trial: 12396323
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) 6 mg/kg
Trial: 8731761
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Ivermectin (IVR) 400 micrograms/kg and Diethylcarbamazine (DEC) 6 mg/kg
Trial: 2013676
Drug: Aspartame (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (up to 2000 mg)
Trial: 7048338
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg labetalol 3-times daily
Trial: 7048338
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg alpha‐methyldopa 3-times daily
Trial: 17414235
Drug: Low-concentration desipramine
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-concentration desipramine (<60 ng/mL)
Trial: 17414235
Drug: Higher concentrations
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher concentrations of desipramine (>60 ng/mL)
Trial: 17414235
Drug: All concentrations
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All concentrations of fluoxetine
Trial: 15808325
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose fish oil (14 g/day)
Trial: 8593095
Drug: Sulacillin (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulacillin (a combination of sodium ampicillin and sulbactam in a 2:1 ratio)
Trial: 2923085
Drug: Milk (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk (900 mg Ca daily)
Trial: 2923085
Drug: Calcium chloride
RxNorm normalized name: Calcium Chloride
DrugBank: Calcium chloride (DB01164)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium chloride (CaCl, 900 mg Ca daily)
Trial: 2923085
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CaCO3, 900 mg Ca daily)
Trial: 2923085
Drug: Calcium supplements
RxNorm normalized name: CALCIUM SUPPLEMENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplements (milk, CaCl, CaCO3)
Trial: 337536
Drug: Intradermal method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal method of vaccination
Trial: 337536
Drug: Japanese BCG
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Japanese BCG vaccine (percutaneous)
Trial: 30170952
Drug: NaHCO3− (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaHCO3− (0.3 g.kg−1 body weight)
Trial: 28615070
Drug: Tildipirosin 4
RxNorm normalized name: tildipirosin
DrugBank: Tildipirosin (DB11470)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tildipirosin 4 mg/kg, subcutaneously (n = 109)
Trial: 10941877
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (0.58 g EPA plus 1.67 g DHA per day)
Trial: 10941877
Drug: Two most
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two most concentrated fish oil supplements
Trial: 10941877
Drug: Linseed oil
RxNorm normalized name: linseed oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linseed oil and fish oil supplements
Trial: 30910492
Drug: Azithromycin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (250 mg orally, once daily 3 times a week for 2 years)
Trial: 26938813
Drug: Blood pressure-lowering
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood pressure-lowering medication (fixed combination of perindopril and indapamide)
Trial: 24215848
Drug: Bevacizumab added
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab added to capecitabine monotherapy
Trial: 22433778
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of sulphadoxine‐pyrimethamine (SP)
Trial: 22433778
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of sulphadoxine‐pyrimethamine (SP)
Trial: 15296819
Drug: placebo/desipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo/desipramine (50 mg)
Trial: 15296819
Drug: placebo/haloperidol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo/haloperidol (2 mg)
Trial: 15296819
Drug: desipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: desipramine (50 mg)/haloperidol (2 mg)
Trial: 15296819
Drug: desipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: desipramine (50 mg)
Trial: 15296819
Drug: haloperidol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol (2 mg)
Trial: 10891977
Drug: High-dose creatine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose creatine (150 mg/kg body weight) followed by low-dose creatine (60 mg/kg)
Trial: 31333778
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy combined with radiotherapy
Trial: 24118234
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D supplements during pregnancy
Trial: 24118234
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplements during pregnancy
Trial: 11866001
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 microg once daily
Trial: 30101329
Drug: Combination (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (both interventions)
Trial: 26610166
Drug: Oxycodone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone treatment
Trial: 26610166
Drug: Oxycodone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone treatment with secretagogues (PGE2, theophylline, ouabain)
Trial: 26610166
Drug: Morphine application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine application
Trial: 24716681
Drug: Tenecteplase plus
RxNorm normalized name: Tenecteplase
DrugBank: Tenecteplase (DB00031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenecteplase plus heparin
Trial: 20858697
Drug: 2 weeks
RxNorm normalized name: Rykindo, 25 mg/2 weeks intramuscular powder for injection, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 weeks of observation followed by one cycle of CC therapy (Group B)
Trial: 12930613
Drug: Mebendazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole (200 mg three times daily for 3 days)
Trial: 12930613
Drug: Secnidazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secnidazole (30 mg/kg, in a single dose)
Trial: 1458765
Drug: 0.2mg moxonidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2mg moxonidine twice daily
Trial: 1458765
Drug: 0.2mg digoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2mg digoxin once daily
Trial: 27997679
Drug: Ledipasvir-sofosbuvir (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ledipasvir-sofosbuvir (90 mg ledipasvir and 400 mg sofosbuvir once daily for 12 weeks)
Trial: 25054452
Drug: Omega-3 supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 supplementation (3.0 g/day of EPA and DHA)
Trial: 22243363
Drug: In-treatment serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment serum K ≤ 3.90
Trial: 19544230
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cytology and histology
Trial: 11878178
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy with technical accessories and splints
Trial: 9747912
Drug: Rilmenidine (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (1-2 mg/day)
Trial: 1956211
Drug: Nifedipine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40 mg/day)
Trial: 3076795
Drug: Methyldopa (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (750 mg daily)
Trial: 28258828
Drug: DNA-TGN concentration
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNA-TGN concentration during maintenance therapy
Trial: 19503783
Drug: Risedronate 150
RxNorm normalized name: risedronate 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 150 mg once a month
Trial: 15186934
Drug: Ivermectin (150-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (150-200 microg/kg body weight) + Albendazole (400 mg)
Trial: 9667292
Drug: Meperidine (0.15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (0.15, 0.30, or 0.60 microg/ml)
Trial: 9667292
Drug: Sufentanil (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (0.1, 0.15, or 0.2 ng/ml)
Trial: 6783707
Drug: Sequential study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential study (6 persons subinoculated with malaria-rich blood)
Trial: 26551196
Drug: Sequential combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combination of both solutions
Trial: 25886386
Drug: Astragaloside IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astragaloside IV (AS-IV) treatment
Trial: 25886386
Drug: 4-phenyl butyric
RxNorm normalized name: 4-Phenyl-n-butyric acid
DrugBank: Phenylbutyric acid (DB06819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-phenyl butyric acid (PBA) treatment
Trial: 24014917
Drug: Statin medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin medication (Group-I)
Trial: 24014917
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin medication (Group-II)
Trial: 1146928
Drug: Ethynylestradiol or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethynylestradiol or mestranol with 2.5 mg norethindrone acetate, 2 mg megestrol acetate, or 0.5 mg norgestrel
Trial: 1146928
Drug: Ethynylestradiol or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethynylestradiol or mestranol (various doses)
Trial: 1146928
Drug: Ethynylestradiol or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethynylestradiol or mestranol with progestational agent
Trial: 1146928
Drug: Long-term oral
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oral contraceptives
Trial: 1146928
Drug: Estrogen agents
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen agents (50 to 75 mug per day)
Trial: 1146928
Drug: Normal controls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal controls (IUD cycles) and chronic treatment with oral contraceptives
Trial: 31332029
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 400 IU b.i.d. plus pioglitazone 45 mg/day
Trial: 29231585
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus western medicine
Trial: 29231585
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both groups after treatment
Trial: 24858769
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) for three menstrual cycles
Trial: 24858769
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) for more than three cycles
Trial: 24858769
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (women who never used ovulation drugs)
Trial: 12605431
Drug: Low power
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low power laser therapy + exercise
Trial: 12605431
Drug: Low power
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low power laser therapy alone
Trial: 9356536
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (100 mg elemental Fe/d)
Trial: 2645988
Drug: Sustained-release morphine
RxNorm normalized name: morphine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release morphine sulfate tablet (MS Contin) given every 12 hours
Trial: 2720576
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine sulfate solution (MSS) given every 4 hours
Trial: 31881407
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (Control Condition)
Trial: 29156152
Drug: DHA-rich supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich supplements
Trial: 23141686
Drug: Negative-pressure wound
RxNorm normalized name: Microcyn Negative-Pressure Wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative-pressure wound therapy (NPWT) applied from the first postoperative day (POD) to the seventh POD.
Trial: 23141686
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no NPWT treatment).
Trial: 11120549
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate (5.6 g/day)
Trial: 11120549
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (6.2 g/day)
Trial: 8421037
Drug: Positive radiographs
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive radiographs treatment (cast for 12 weeks)
Trial: 3891284
Drug: Pentazocine 0.5
RxNorm normalized name: naloxone-pentazocine 0.5 mg-50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine 0.5 mg/kg
Trial: 30656404
Drug: Dexmedetomidine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1.0 µg/kg/hr for 1 hour, followed by 0.2 µg/kg/hr)
Trial: 25407009
Drug: Group schema
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group schema therapy (GST)
Trial: 25276703
Drug: Inhaled lavender
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled lavender scent 30 minutes before IUD insertion
Trial: 25276703
Drug: Placebo inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo inhalation 30 minutes before IUD insertion
Trial: 25276703
Drug: Inhaled lavender
RxNorm normalized name: LAVENDER
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled lavender scent
Trial: 16104966
Drug: CDC (calculus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDC (calculus deattachment with Gracey curettes and brushing with saline solution)